US BIOSECURE Act passed by Congress

Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), will put in motion US government-wide restrictions on ‘biotechnology companies of concern’ and eventually bar agencies from procuring their biotech equipment or services.

In 2024, Congress sought to insert the BIOSECURE Act into the NDAA, but it ultimately was not included in the final version due to concerns raised by various stakeholders and Members of Congress. After months of negotiations over the broader NDAA package, Congressional leadership gave the language…